OTCMKTS:IPSEY IPSEN (IPSEY) Stock Price, News & Analysis $46.50 0.00 (0.00%) As of 09/9/2026 12:55 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartDividendNews and TrendsShort Interest About IPSEN Stock (OTCMKTS:IPSEY) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get IPSEN alerts:Sign Up Key Stats Today's Range$46.50▼$46.5050-Day Range$44.07▼$49.1552-Week Range$32.02▼$51.10Volume215 shsAverage Volume648 shsMarket Capitalization$15.59 billionP/E RatioN/ADividend Yield0.65%Price TargetN/AConsensus RatingReduce Company Overview Ipsen S.A. is a France-based biopharmaceutical company that develops and commercializes specialty medicines for serious diseases. Its primary focus areas are oncology, rare diseases and neuroscience, with research and development activities aimed at addressing conditions that often have limited treatment options. The company’s portfolio includes medicines such as Somatuline (lanreotide) for certain neuroendocrine tumors and endocrine disorders, Dysport (abobotulinumtoxinA) for selected neurological and muscular conditions, and oncology treatments including Cabometyx and Onivyde. Ipsen also develops and commercializes therapies through partnerships and acquisitions, expanding its presence in rare and specialty diseases. Founded in 1929, Ipsen is headquartered in Boulogne-Billancourt, France, and serves patients and healthcare professionals across international markets. The company is led by Chief Executive Officer David Loew and operates through a global network supporting research, manufacturing and commercial activities.AI Generated. May Contain Errors. Read More Receive IPSEY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for IPSEN and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. IPSEY Stock News HeadlinesIPSEN (OTCMKTS:IPSEY) Given Consensus Recommendation of "Hold" by BrokeragesSeptember 1, 2026 | americanbankingnews.comIpsen ADRAugust 21, 2026 | marketwatch.comYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options can give you up to 12 times the leverage of stocks — with a fraction of the capital tied up. This free guide lays it all out in plain English — from A to Z, with step-by-step examples you can follow in your own account.September 11 at 1:00 AM | Profits Run (Ad)Ipsen completes acquisition of Kartos Therapeutics, strengthening late-stage Oncology pipelineAugust 21, 2026 | markets.businessinsider.comIpsen S.A. (IPSEY) Q2 2026 Earnings Call TranscriptAugust 1, 2026 | seekingalpha.comIpsen delivers excellent H1 2026 results and upgrades its full-year guidanceJuly 30, 2026 | markets.businessinsider.comIpsen nominates Catherine Bradley to its Board of Directors as independent DirectorJuly 29, 2026 | markets.businessinsider.comIpsen Pharma: Ipsen provides update on Phase III BOLD trial in biliary atresiaJuly 24, 2026 | finanznachrichten.deSee More Headlines IPSEY Stock Analysis - Frequently Asked Questions How have IPSEY shares performed this year? IPSEN's stock was trading at $36.3596 at the beginning of the year. Since then, IPSEY shares have increased by 27.9% and is now trading at $46.50. How do I buy shares of IPSEN? Shares of IPSEY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today9/10/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolOTCMKTS:IPSEY CIKN/A Webwww.ipsen.com Phone(315) 833-5000Fax33-01-58-33-50-01Employees5,535Year Founded1929Profitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio1.96 Quick Ratio1.79 Sales & Book Value Annual Sales$4.16 billion Price / Sales3.75 Cash Flow$5.51 per share Price / Cash Flow8.44 Book Value$14.64 per share Price / Book3.18Miscellaneous Outstanding Shares335,260,000Free FloatN/AMarket Cap$15.59 billion OptionableNot Optionable Beta0.43 Social Links 7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free Report This page (OTCMKTS:IPSEY) was last updated on 9/11/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...Investors Alley | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredMy top 3 AI picks for the next decadeAlexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IPSEN Please log in to your account or sign up in order to add this asset to your watchlist. Share IPSEN With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IPSEY Stock Alerts